Preferred Label : enmetazobactam;
MeSH Hyperonym : 1H-1,2,3-triazolium, 3-(((2S,3S,5R)-2-carboxy-3-methyl-4,4-dioxido-7-oxo-4-thia-1-azabicyclo(3.2.0)hept-3-yl)methyl)-1-methyl-,
inner salt;
UNII : 80VUN7L00C;
Origin ID : C000656730;
UMLS CUI : C5392310;
Currated CISMeF NLP mapping
MeSH term(s) associated for indexing
Pharmacological action(s)
Record concept(s)
Semantic type(s)
UMLS correspondences (same concept)
https://www.has-sante.fr/jcms/p_3605176/fr/exblifep-cefepime/enmetazobactam-lactamines-inhibiteurs-de-lactamase
2025
false
false
false
France
treatment outcome
insurance, health, reimbursement
cefepime, enmetazobactam drug combination
drug combinations
Cefepime
enmetazobactam
anti-bacterial agents
beta-Lactamase Inhibitors
adult
Complicated urinary tract infection
pyelonephritis
Healthcare-Associated Pneumonia
pneumonia, ventilator-associated
enterobacteriaceae infections
Infection caused by carbapenemase-producing Enterobacteriaceae (disorder)
OXA-48 carbapenemase-producing bacteria (organism)
infusions, intravenous
cefepime and beta-lactamase inhibitor
bacteremia
evaluation of the transparency committee
---
https://www.ema.europa.eu/en/medicines/human/EPAR/exblifep
2024
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
cefepime, enmetazobactam drug combination
cefepime, enmetazobactam drug combination
enmetazobactam
enmetazobactam
Cefepime
Cefepime
beta-Lactamase Inhibitors
beta-Lactamase Inhibitors
anti-bacterial agents
anti-bacterial agents
adult
pyelonephritis
urinary tract infections
Healthcare-Associated Pneumonia
pneumonia, ventilator-associated
bacteremia
infusions, intravenous
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
cefepime and beta-lactamase inhibitor
drug evaluation, preclinical
OXA-48 carbapenemase-producing bacteria (organism)
Infection caused by carbapenemase-producing Enterobacteriaceae (disorder)
---